MedPath
FDA Product

Bupropion Hydrochloride

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Bupropion Hydrochloride

50268-141

Regulatory Information

50268-141

ANDA077284

C73584

January 9, 2024

USA

BuPROPion Hydrochloride Extended-Release Tablets USP Rx Only These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BuPROPion Hydrochloride Extended-Release Tablets, USP for oral use Initial U.S. Approval: 1985

HUMAN PRESCRIPTION DRUG LABEL

10

Company Information

AvPAK

832926666

Active Ingredients

ISOPROPYL ALCOHOL

Code: ND2M416302

Class Code: IACT

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

BUPROPION HYDROCHLORIDE

Quantity: 300 mg in 1 1

Code: ZG7E5POY8O

Class Code: ACTIB

ETHYLCELLULOSES

Code: 7Z8S9VYZ4B

Class Code: IACT

HYDROCHLORIC ACID

Code: QTT17582CB

Class Code: IACT

METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A

Code: NX76LV5T8J

Class Code: IACT

POVIDONE

Code: FZ989GH94E

Class Code: IACT

HYDROXYPROPYL CELLULOSE (1600000 WAMW)

Code: RFW2ET671P

Class Code: IACT

ALCOHOL

Code: 3K9958V90M

Class Code: IACT

HYDROGENATED COTTONSEED OIL

Code: Z82Y2C65EA

Class Code: IACT

Active Moieties

BUPROPION

Code: 01ZG3TPX31

© Copyright 2025. All Rights Reserved by MedPath